Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 9/20 | 0.53 |
| ▸ | HCRTR2 | O43614 | 5/20 | 0.44 |
| ▸ | APP | P05067 | 3/20 | 0.42 |
| ▸ | MAOA | P21397 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11091074 | 0.84 | MAOB (0.56) | MAOBHCRTR2ATM | |
| SCHEMBL5359397 | 0.80 | MAOB (0.52) | MAOBHCRTR2ATMNR1H3 | |
| SCHEMBL5347623 | 0.80 | MAOB (0.52) | MAOBHCRTR2ATMNR1H3 | |
| SCHEMBL5347615 | 0.80 | MAOB (0.52) | MAOBHCRTR2ATMNR1H3 | |
| SCHEMBL10713369 | 0.80 | MAOB (0.52) | MAOBHCRTR2KDM4EATMNR1H3 | |
| SCHEMBL11116967 | 0.78 | MAOB (0.48) | MAOBHCRTR2 | |
| SCHEMBL10712815 | 0.77 | MAOB (0.48) | MAOBHCRTR2NR1H3 | |
| SCHEMBL5351629 | 0.76 | MAOB (0.48) | MAOBHCRTR2NR1H3 | |
| SCHEMBL10714188 | 0.76 | MAOB (0.50) | MAOBNR1H3 | |
| SCHEMBL11283939 | 0.76 | ALDH1A1 (0.50) | MAOBHCRTR2KDM4ENR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4460580-A | N-Alkylated aminoalcohols and their pharmaceutical compositions useful for the treatment of cardiac insufficiency | CIBA-GEIGY CORPORATION (US) | 1984-07-17 | — | — | US | disclosed |